Effects of hydroxyethyl starch, gelatin and dextran on endothelium-derived relaxation in porcine coronary arteries

Pharmacology

Volumn 86, Issue 5-6, 2010, Pages 267-272

  Dagtekin, Oguzhan ^a,d   Klisa, Maite Ann Katrin ^b   Gerbershagen, Hans Jürgen ^c   Marcus, Hanke ^a   Krep, Henning ^a   Teschendorf, Peter ^a   Fischer, Jürgen Hartmut ^b  

^a Department of Anaesthesiology and Intensive Care Medicine ^*  (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Colloid solutions; Endothelial function; Endothelium derived hyperpolarizing factor

Indexed keywords

BRADYKININ; DEXTRAN; ENDOTHELIUM DERIVED RELAXING FACTOR; GELATIN; HETASTARCH; INDOMETACIN; N NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONCENTRATION (PARAMETERS); CORONARY ARTERY; ENDOTHELIUM DEPENDENT RELAXATION; FOLLOW UP; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; BIOLOGICAL FACTORS; CORONARY VESSELS; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GELATIN; HETASTARCH; INDOMETHACIN; NITRIC OXIDE; NITROARGININE; SWINE;

EID: 77958472399     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320955     Document Type: Article

References (39)

1. Boulanger CM, Vanhoutte PM: The Endothelium: A Pivotal Role in Health and Cardiovascular Disease. Courbevoie, Servier International, 1994, pp 11-20.
2. Félétou M, Vanhoutte PM: Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006; 26: 1215-1225.
3. Fleming I, Bauersachs J, Busse R: Paracrine function of the coronary vascular endothelium. Mol Cell Biochem 1996; 157: 137-145.
4. He GW: Effect and mechanism of cardioplegic arrest on the coronary endotheliumsmooth muscle interaction. Clin Exp Pharmacol Physiol 1998; 25: 831-835.
5. Brecher ME, Owen HG, Bandarenko N: Alternatives to albumin: starch replacement for plasma exchange. J Clin Apher 1997; 12: 146-153.
6. Nitsch E: Volumenersatz mit künstlichen Kolloiden. Anästhesiol Intensivmed Notfallmed Schmerzther 1998; 33: 255-260.
7. Gruber UF: Blutersatz. Berlin, Springer, 1968, pp 57-105.
8. Dagtekin O, Krep H, Fischer JH: Hydroxyethyl starch inhibits endothelium-derived relaxation in porcine coronary arteries. Pharmacology 2008; 81: 241-245.
9. Fischer JH, Steinhoff M: Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries. Eur J Cardiothoracic Surg 2005; 28: 801-804.
10. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, Webb AR: The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: an in vitro study. Intensive Care Med 1994; 20: 37-41.
11. Rittoo D, Gosling P, Simms MH, Smith SRG, Vohra RK: The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005; 30: 520-524.
12. Handrigan MT, Burns AR, Donnachie EM, Bowden RA: Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005; 24: 434-439.
13. Nohé B, Burchard M, Zanke C, Eichner M, Krump-Konvalinkova V, Kirkpatrick CJ, Dieterich HJ: Endothelial accumulation of hydroxyethyl starch and functional consequences on leucocyte-endothelial interactions. Eur Surg Res 2002; 34: 364-372.
14. Nohé B, Johannes T, Reutershan J, Rothmund A, Haeberle HA, Ploppa A, Schroeder TH, Dieterich HJ: Synthetic colloids attenuate leukocyte- endothelial interactions by inhibition of integrin function. Anesthesiology 2005; 103: 759-767.
15. Vincent JL: The pros and cons of hydroxyethyl starch solutions. Anesth Analg 2007; 104: 484-486.
16. Ruttmann TG, James MF, Viljoen JF: Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412-414.
17. Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W: Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 1995; 74: 1447-1451.
18. Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM: Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998; 80: 204-207.
19. Boldt J, Brosch C, Röhm K, Papsdorf M, Mengistu A: Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth 2008; 100: 457-464.
20. Batlle J, del Rio F, Lopez Fernandez MF, Martin R, Lopez BA: Effect of dextran on factor VIII/von Willebrand factor structure and function. Thromb Haemost 1985; 54: 697-699.
21. Bergman A, Andreen M, Blomback M: Plasma substitution with 3% dextran-60 in orthopaedic surgery: influence on plasma colloid osmotic pressure, coagulation parameters, immunoglobulins and other plasma constituents. Acta Anaesthesiol Scand 1990; 34: 21-29.
22. Zhang B, Wieslander JB: Dextran's antithrombotic properties in small arteries are not altered by low-molecular-weight heparin or the fibrinolytic inhibitor tranexamic acid: an experimental study. Microsurgery 1993; 14: 289-295.
23. Laubenthal H, Messmer K: Allergic reactions to dextrans; in Baron JF (ed): Plasma Volume Expansion. Paris, Arnette Blackwell, 1992.
24. Gombocz K, Beledi A, Alotti N, Kecskés G, Gábor V, Bogár L, Kõszegi T, Garai J: Influence of dextran-70 on systemic inflammatory response and myocardial ischaemia-reperfusion following cardiac operations. Crit Care 2007; 11:R87.
25. Otsuka A, Mikami H, Tsunetoshi T, Katahira K, Moriguchi A, Rakugi H, Suzuki N, Ogihara T: Increased plasma level of endothelin with vasoconstriction after dextran infusion. Biochem Int 1990; 22: 353-359.
26. McNeill JR: Role of endothelin in regulation of resistance, fluid-exchange, and capacitance functions of the systemic circulation. Can J Physiol Pharmacol 2003; 81: 522-532.
27. Schnitzer JE, Carley WW, Palade GE: Specific albumin binding to microvascular endothelium in culture. Am J Physiol 1988; 254:H425-H437.
28. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF: Contrasting Effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006; 104: 1223-1231.
29. Boldt J, Schölhorn T, Mayer J, Piper S, Suttner S: The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing MAJOR abdominal surgery. Anesth Analg 2006; 103: 191-199.
30. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A: Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albuminbased priming strategy. Anesth Analg 2009; 109: 1752-1762.
31. Brandes RP, Behra A, Lebherz C, Böger RH, Bode-Böger SM, Phivthong-Ngam L, Mügge A: N(G)-nitro- L -arginine- and indomethacin- resistant endothelium dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis 1997; 135: 49-55.
32. Golding EM, You J, Robertson CS, Bryan RM Jr: Potentiated endothelium derived hyperpolarizing factor-mediated dilations in cerebral arteries following mild head injury. J Neurotrauma 2001; 18: 691-697.
33. Malmsjo M, Bergdahl A, Zhao XH, Sun XY, Hedner T, Edvinsson L, Erlinge D: Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res 1999; 43: 200-209.
34. Marrelli SP, Khorovets A, Johnson TD, Childres WF, Bryan RM Jr: P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia/reperfusion. Am J Physiol 1999; 276:H33-H41.
35. Marrelli SP: Altered endothelial Ca 2+ regulation after ischemia/reperfusion produces potentiated endothelium-derived hyperpolarizing factor-mediated dilations. Stroke 2002; 33: 2285-2291.
36. McLean PG, Aston D, Sarkar D, Ahluwalia A: Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 2002; 90: 465-472.
37. Miura H, Wachtel RE, Liu Y, Loberiza FR Jr, Saito T, Miura M, Gutterman DD: Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circulation 2001; 103: 1992-1998.
38. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD: Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003; 92:e31-e40.
39. Thollon C, Fournet-Bourguignon MP, Saboureau D, Lesage L, Reure H, Vanhoutte PM, Vilaine JP: Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br J Pharmacol 2002; 136: 1153-1161.